Consolidated Statements of Income (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010
REVENUES	$ 1,043	$ 2,761	$ 2,224	$ 3,723
COST OF SALES	233	4,517	1,692	5,213
GROSS PROFIT (LOSS)	810	(1,756)	532	(1,490)
Research and development	30,643	30,002	48,360	38,590
Depreciation and amortization	174	359	358	650
Bad debt expense			203
General and administrative	273,772	505,754	512,451	754,315
Total Operating Expenses	304,589	536,115	561,372	793,555
OPERATING LOSS	(303,779)	(537,871)	(560,840)	(795,045)
Other income	917	96	3,124	610
Total Other Income	917	96	3,124	610
Loss before income taxes and noncontrolling interest	(302,862)	(537,775)	(557,716)	(794,435)
NET LOSS	(302,862)	(537,775)	(557,716)	(794,435)
Less: Net loss attributable to noncontrolling interest	(18,417)	(18,967)	(35,677)	(32,267)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(284,445)	(518,808)	(522,039)	(762,168)
Foreign currency translation adjustments	40,114	17,923	47,131	56,127
Total Other Comprehensive Income (Loss)	40,114	17,923	47,131	56,127
COMPREHENSIVE LOSS	$ (262,748)	$ (519,852)	$ (510,585)	$ (738,308)
BASIC AND DILUTED LOSS PER SHARE	$ 0.00	$ (0.01)	$ 0.00	$ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	116,647,807	44,037,966	113,885,135	84,856,464